Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CLEVELAND, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its year-end 2016 financial results at approximately 4:00 PM Eastern Time on Thursday, March 9, 2017, and will...
-
CLEVELAND, Feb. 01, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) (“Athersys”) today announced the closing of its previously announced underwritten public offering of 22,772,300 shares of...
-
CLEVELAND, Jan. 27, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) (“Athersys”) today announced the pricing of its previously announced underwritten public offering of 19,802,000 shares of...
-
CLEVELAND, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) (“Athersys”) announced today that it intends to offer for sale shares of its common stock, par value $0.001 per share...
-
CLEVELAND, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that through its Belgian subsidiary, ReGenesys BVBA (ReGenesys), it has entered into an agreement with a...
-
CLEVELAND, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) today announced its financial results for the three months ended September 30, 2016. Highlights of the third quarter of...
-
CLEVELAND, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present at the Stifel 2016 Healthcare Conference at the Lotte...
-
CLEVELAND, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its third quarter 2016 financial results at approximately 4:00 PM Eastern Time on Wednesday, November 9, 2016,...
-
CLEVELAND, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that it has received agreement from the U.S. Food and Drug Administration (FDA) under a Special Protocol...
-
CLEVELAND, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today the successful completion of Japan’s Pharmaceutical and Medical Devices Agency (PMDA) review of the...